Veeva Systems, which offers life sciences companies cloud-based commercial management software and business consulting services, is venturing into the consumer-facing side of things with the ...

PLEASANTON, Calif., March 10, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced the acquisition of Ostro, the leading brand engagement platform for life sciences that gives patients and ...

Veeva Systems Inc. (VEEV) reported strong financial results for the fourth quarter of fiscal 2026, surpassing analysts’ expectations. The company achieved an earnings per share (EPS) of $2.06, ...

For the quarter ended January 2026, Veeva Systems (VEEV) reported revenue of $835.95 million, up 16% over the same period last year. EPS came in at $2.06, compared to $1.74 in the year-ago quarter.

Veeva's laser focus on the life sciences industry has made it a leader in this corner of the cloud market. The company could grow its revenue -- and share price -- at a good clip in the next four ...

The past six months have been rough for Veeva Systems (NYSE: VEEV). The stock has declined 35% over this period as the market fears that mounting competition will lead to disappointing financial ...

As noted previously, when Veeva ended its licence agreement with Salesforce, it not only triggered a battle royale for domination of big pharma CRM, it began the first massive use case for adoption of ...

The latest announcement is out from Veeva Systems ( (VEEV)). On January 5, 2026, Veeva Systems announced that its board had authorized the company’s first-ever share repurchase program, allowing the ...

Veeva Systems (NYSE: VEEV) is currently in Phase 18, the final stage of its 18-phase Adhishthana cycle on the weekly charts. The company recently reported earnings, and the stock has fallen sharply ...